Preoperative Thyrotropin Serum Concentrations Gradually Increase from Benign Thyroid Nodules to Papillary Thyroid Microcarcinomas Then to Papillary Thyroid Cancers of Larger Size
2012

TSH Levels and Thyroid Cancer

Sample size: 386 publication Evidence: moderate

Author Information

Author(s): Zafon Carles, Obiols Gabriel, Baena Juan Antonio, CastellvĂ­ Josep, Dalama Belen, Mesa Jordi

Primary Institution: Hospital General Universitari Vall d'Hebron

Hypothesis

Does the level of preoperative serum thyrotropin (TSH) correlate with the presence and size of thyroid cancer?

Conclusion

Higher TSH levels are associated with a diagnosis of differentiated thyroid carcinoma (DTC) and increase with tumor size.

Supporting Evidence

  • The mean TSH concentration was 1.36 mU/L in benign patients and 2.08 mU/L in malignant cases.
  • Significant differences in TSH levels were found between benign and larger thyroid cancers.
  • Higher TSH levels were associated with more advanced cancer stages.

Takeaway

The more TSH you have in your blood, the more likely it is that you have thyroid cancer, especially if the cancer is bigger.

Methodology

The study evaluated preoperative serum TSH levels in 386 patients with nodular thyroid disease and compared levels between benign and malignant cases.

Potential Biases

Potential bias due to the exclusion of patients with known thyroid cancer and those without available TSH levels.

Limitations

The study did not analyze thyroid antibodies in a quarter of patients, which may affect results.

Participant Demographics

The benign group included 250 females (80.6%) and 60 males (19.4%), with a mean age of 54.4 years; the malignant group included 60 females (78.9%) and 16 males (21.1%), with a mean age of 49.3 years.

Statistical Information

P-Value

0.0013

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1155/2012/530721

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication